AI and Laboratory Led IdentificatioN (ALL IN) of Post-Acute Sequelae of SARS-CoV-2 (PASC or ‘long COVID’)

Traditional diagnostics have failed the approximate >10% of Australians who are living with long COVID. The Medical Research Future Fund (MRFF) has funded this study to help identify new biomarkers to diagnose this disease as well as help predict the course of the disease over time. This will improve the clinical care that long COVID patients receive.

This study will recruit two groups of individuals: those living with PASC-CVS (long COVID), and those who have had a SARS-CoV-2 infection but did not experience persistent symptoms (recovered). If you are living with long COVID or have recovered from a SARS-CoV-2 infection, we invite you to participate in our study. This will involve filling out a survey and donating some blood. Once you have filled out the survey you can donate blood at any participating collection centre (QML). You may be then contacted 6 months later to fill out an additional survey on your long COVID symptoms.

Your samples will be used for a variety of different laboratory assays to identify new diagnostic and prognostic biomarkers of long COVID. We are also happy to keep you informed about our latest findings as the research progresses. Join our study today and help us improve our understanding and treatment of this potentially debilitating condition.

Should you wish to take part in this study or want to know more details, please contact either:

A/Prof Kirsty Short, Chief Investigator, School of Chemical and Molecular Biosciences The University of Queensland via email at k.short@uq.edu.au and all.in.pasc@gmail.com or Miss Andrea Corner, ALL IN Study Coordinator and Research Assistant, School of Chemical and Molecular Biosciences The University of Queensland via email at a.corner@uq.edu.au and all.in.pasc@gmail.com